Azathioprine Therapy in Polymyositis

Merrill Benson, Marlene A. Aldo

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Four patients with polymyositis were treated with azathioprine. Each had been treated initially with prednisone and had become unresponsive or suffered severe complications of steroid therapy. Response to azathioprine therapy, as measured by improvement in muscle strength and decrease in serum enzyme levels, was favorable in all patients. Treatment with azathioprine permitted decrease in prednisone dosage with resultant resolution of steroid side effects. No important complications of azathioprine therapy were encountered. We advocate the use of azathioprine in the treatment of polymyositis.

Original languageEnglish (US)
Pages (from-to)547-551
Number of pages5
JournalArchives of Internal Medicine
Volume132
Issue number4
DOIs
StatePublished - 1973
Externally publishedYes

Fingerprint

Polymyositis
Azathioprine
Prednisone
Steroids
Therapeutics
Muscle Strength
Enzymes
Serum

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Azathioprine Therapy in Polymyositis. / Benson, Merrill; Aldo, Marlene A.

In: Archives of Internal Medicine, Vol. 132, No. 4, 1973, p. 547-551.

Research output: Contribution to journalArticle

Benson, Merrill ; Aldo, Marlene A. / Azathioprine Therapy in Polymyositis. In: Archives of Internal Medicine. 1973 ; Vol. 132, No. 4. pp. 547-551.
@article{cff30fbd6b794d95bb5703eafd34ecbd,
title = "Azathioprine Therapy in Polymyositis",
abstract = "Four patients with polymyositis were treated with azathioprine. Each had been treated initially with prednisone and had become unresponsive or suffered severe complications of steroid therapy. Response to azathioprine therapy, as measured by improvement in muscle strength and decrease in serum enzyme levels, was favorable in all patients. Treatment with azathioprine permitted decrease in prednisone dosage with resultant resolution of steroid side effects. No important complications of azathioprine therapy were encountered. We advocate the use of azathioprine in the treatment of polymyositis.",
author = "Merrill Benson and Aldo, {Marlene A.}",
year = "1973",
doi = "10.1001/archinte.1973.03650100063012",
language = "English (US)",
volume = "132",
pages = "547--551",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Azathioprine Therapy in Polymyositis

AU - Benson, Merrill

AU - Aldo, Marlene A.

PY - 1973

Y1 - 1973

N2 - Four patients with polymyositis were treated with azathioprine. Each had been treated initially with prednisone and had become unresponsive or suffered severe complications of steroid therapy. Response to azathioprine therapy, as measured by improvement in muscle strength and decrease in serum enzyme levels, was favorable in all patients. Treatment with azathioprine permitted decrease in prednisone dosage with resultant resolution of steroid side effects. No important complications of azathioprine therapy were encountered. We advocate the use of azathioprine in the treatment of polymyositis.

AB - Four patients with polymyositis were treated with azathioprine. Each had been treated initially with prednisone and had become unresponsive or suffered severe complications of steroid therapy. Response to azathioprine therapy, as measured by improvement in muscle strength and decrease in serum enzyme levels, was favorable in all patients. Treatment with azathioprine permitted decrease in prednisone dosage with resultant resolution of steroid side effects. No important complications of azathioprine therapy were encountered. We advocate the use of azathioprine in the treatment of polymyositis.

UR - http://www.scopus.com/inward/record.url?scp=84910347614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910347614&partnerID=8YFLogxK

U2 - 10.1001/archinte.1973.03650100063012

DO - 10.1001/archinte.1973.03650100063012

M3 - Article

VL - 132

SP - 547

EP - 551

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 4

ER -